Correlation study of biological characteristics of non-small cell lung cancer A549 cells after transfecting plasmid by microbubble ultrasound contrast agent

被引:8
作者
Guo, Xuan-Yan [1 ]
Lu, Man [1 ]
Chen, Xue-Qing [1 ]
He, Fan-Ding [1 ]
Li, Ang [2 ]
机构
[1] Peoples Hosp Sichuan Prov, Acad Sci Sichuan Prov, Ultrason Dept, Chengdu 610072, Sichuan Provinc, Peoples R China
[2] Sichuan Univ, West China Hosp, Pancreat Surg, Chengdu 610041, Sichuan Provinc, Peoples R China
关键词
Microbubble ultrasound contrast agent; miR-224; miR-122a; Non-small cell lung cancer; MICRORNAS; EXPRESSION; CHEMOTHERAPY; LIVER; IDENTIFICATION; DIAGNOSIS; THERAPY; TARGET; BLOOD;
D O I
10.1016/j.apjtm.2016.04.007
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To explore the role of the abnormal expression of miRNAs in the development process of non-small cell lung cancer and the feasibility of ultrasound microbubble-mediated gene therapy after transfecting antisense miRNA-224 and miRNA-122a plasmids into non-small cell lung cancer A549 cells. Methods: Antisense miRNA-224 and miRNA-122a plasmids were transfected into nonsmall cell lung cancer A549 cells on the optimal ultrasound microbubble-mediated condition. We set up a control group. The cell proliferation activity, apoptosis, invasion ability were detected by MTT assay, Annexin V-PE, Transwell invasion experiment and colony formation assay, respectively. Results: The expression of miRNA-224 decreased and the expression of miRNA-122a rose after the plasmids of target genes were transfected into non-small cell lung cancer A549 cells, and there were significant differences when compared with those of the control group (P < 0.05). After the plasmids of target genes were transfected into A549 cells, the growth of antisense miRNA-224 and miRNA-122a were inhibited, and the differences were significant as compared with the control group (P < 0.05). Besides, the inhibition of miRNA-122a group was the most significant and there was statistically significant difference as compared with miRNA-224 group (t = -4.694, P = 0.009). After the plasmids of target genes were transfected into A549 cells, the proportion of apoptotic cells increased, the invasive cells were decreased and the clone ability reduced, and also there was a significant difference as compared with those of the control group (P < 0.05). What's more, the apoptotic peak appeared in miRNA-122a group. Its invasion ability decreased most obviously (40.25 +/- 3.97/visual field), the number of clone ability was 104.93 +/- 4.87 and the inhibitory effect was the most obviously. There was statistically significant difference as compared with other groups (P < 0.05). Conclusions: A549 cells transfected by ultrasound microbubble-mediated antisense miRNA-224 and miRNA-122a plasmids possessed good transfection efficiency. The cell growth, invasion and colony-forming abilities of transfected A549 cells were suppressed, which laid a solid foundation for the gene therapy of non-small cell lung cancer.
引用
收藏
页码:582 / 586
页数:5
相关论文
共 31 条
[1]   Analysis of PTEN in two BRCA1 and BRCA2 wild-type familial breast cancer patients [J].
Akouchekian, Mansoureh ;
Hemati, Simin ;
Kachoei, Zohreh Ataei .
JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2015, 20 (06) :629-630
[2]   MicroRNA-224 Induces G1/S Checkpoint Release in Liver Cancer [J].
An, Fangmei ;
Olaru, Alexandru V. ;
Mezey, Esteban ;
Xie, Qing ;
Li, Ling ;
Piontek, Klaus B. ;
Selaru, Florin M. .
JOURNAL OF CLINICAL MEDICINE, 2015, 4 (09) :1713-1728
[3]   Clinical observation of docetaxel or gemcitabine combined with cisplatin in the chemotherapy after surgery for stage II-III non-small cell lung cancer [J].
Chen, Qiu-Qiang ;
Ji, Xue-Xian ;
Zhou, Xiao ;
Shi, Qi-Lin ;
Yu, Huan-Ming ;
Fu, Heng-Qin ;
Ji, Guo-Ping .
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2015, 19 (04) :323-326
[4]   MicroRNA-224: as a potential target for miR-based therapy of cancer [J].
Chen, Wei ;
Fan, Xue-mei ;
Mao, Ling ;
Zhang, Jun-ying ;
L, Jian, I ;
Wu, Jian-zhong ;
Tang, Jin-hai .
TUMOR BIOLOGY, 2015, 36 (09) :6645-6652
[5]   Crizotinib as first line therapy for advanced ALK-positive non-small cell lung cancers [J].
Chuang, Jody C. ;
Neal, Joel W. .
TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (05) :639-641
[6]   Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma [J].
Diao, Shu ;
Zhang, Jin-fang ;
Wang, Hua ;
He, Ming-liang ;
Lin, Marie Chia-mi ;
Chen, Yangchao ;
Kung, Hsiang-fu .
PROTEOMICS, 2010, 10 (20) :3723-3731
[7]   Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children [J].
Gao, Liwei ;
Ai, Junhong ;
Xie, Zhengde ;
Zhou, Chen ;
Liu, Chunyan ;
Zhang, Hui ;
Shen, Kunling .
VIROLOGY JOURNAL, 2015, 12
[8]   Correlation between expression of epidermal growth factor receptor and adverse reactions after chemotherapy of advanced non-small-cell lung cancer [J].
Hao, Zerui ;
Tian, Chunyan ;
Yang, Futang ;
Zhang, Jihong .
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2015, 31 (05) :1115-1120
[9]   Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma [J].
Hu, Jinsong ;
Xu, Ye ;
Cai, Sanjun .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2015, 20
[10]   Definitive radiotherapy alone over 60 Gy for patients unfit for combined treatment to stage II-III non-small cell lung cancer: retrospective analysis [J].
Joo, Ji Hyeon ;
Song, Si Yeol ;
Kim, Su Ssan ;
Jeong, Yuri ;
Jeong, Seong-Yun ;
Choi, Wonsik ;
Choi, Eun Kyung .
RADIATION ONCOLOGY, 2015, 10